HOLOGIC INC (HOLX)

US4364401012 - Common Stock

73.78  +1.2 (+1.65%)

After market: 73.78 0 (0%)

Fundamental Rating

6

Overall HOLX gets a fundamental rating of 6 out of 10. We evaluated HOLX against 192 industry peers in the Health Care Equipment & Supplies industry. HOLX scores excellent points on both the profitability and health parts. This is a solid base for a good stock. HOLX has a valuation in line with the averages, but on the other hand it scores bad on growth.



8

1. Profitability

1.1 Basic Checks

In the past year HOLX was profitable.
In the past year HOLX had a positive cash flow from operations.
Of the past 5 years HOLX 4 years were profitable.
HOLX had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

With an excellent Return On Assets value of 5.35%, HOLX belongs to the best of the industry, outperforming 83.85% of the companies in the same industry.
With an excellent Return On Equity value of 9.63%, HOLX belongs to the best of the industry, outperforming 85.42% of the companies in the same industry.
With an excellent Return On Invested Capital value of 8.53%, HOLX belongs to the best of the industry, outperforming 88.02% of the companies in the same industry.
HOLX had an Average Return On Invested Capital over the past 3 years of 16.15%. This is significantly above the industry average of 8.46%.
The 3 year average ROIC (16.15%) for HOLX is well above the current ROIC(8.53%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 5.35%
ROE 9.63%
ROIC 8.53%
ROA(3y)13.44%
ROA(5y)10.53%
ROE(3y)26.72%
ROE(5y)22.35%
ROIC(3y)16.15%
ROIC(5y)14.15%

1.3 Margins

The Profit Margin of HOLX (11.78%) is better than 88.02% of its industry peers.
HOLX's Profit Margin has declined in the last couple of years.
HOLX has a better Operating Margin (22.37%) than 95.31% of its industry peers.
In the last couple of years the Operating Margin of HOLX has grown nicely.
The Gross Margin of HOLX (55.12%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of HOLX has remained more or less at the same level.
Industry RankSector Rank
OM 22.37%
PM (TTM) 11.78%
GM 55.12%
OM growth 3Y-8.49%
OM growth 5Y8.14%
PM growth 3Y-27.37%
PM growth 5YN/A
GM growth 3Y-2.18%
GM growth 5Y1.16%

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), HOLX is creating some value.
The number of shares outstanding for HOLX has been reduced compared to 1 year ago.
The number of shares outstanding for HOLX has been reduced compared to 5 years ago.
The debt/assets ratio for HOLX has been reduced compared to a year ago.

2.2 Solvency

HOLX has an Altman-Z score of 4.20. This indicates that HOLX is financially healthy and has little risk of bankruptcy at the moment.
HOLX has a Altman-Z score of 4.20. This is in the better half of the industry: HOLX outperforms 72.92% of its industry peers.
HOLX has a debt to FCF ratio of 2.71. This is a good value and a sign of high solvency as HOLX would need 2.71 years to pay back of all of its debts.
HOLX's Debt to FCF ratio of 2.71 is amongst the best of the industry. HOLX outperforms 87.50% of its industry peers.
HOLX has a Debt/Equity ratio of 0.52. This is a neutral value indicating HOLX is somewhat dependend on debt financing.
HOLX has a Debt to Equity ratio of 0.52. This is in the lower half of the industry: HOLX underperforms 66.15% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF 2.71
Altman-Z 4.2
ROIC/WACC0.9
WACC9.53%

2.3 Liquidity

A Current Ratio of 3.97 indicates that HOLX has no problem at all paying its short term obligations.
With a Current ratio value of 3.97, HOLX perfoms like the industry average, outperforming 59.38% of the companies in the same industry.
HOLX has a Quick Ratio of 3.29. This indicates that HOLX is financially healthy and has no problem in meeting its short term obligations.
With a decent Quick ratio value of 3.29, HOLX is doing good in the industry, outperforming 62.50% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.97
Quick Ratio 3.29

3

3. Growth

3.1 Past

HOLX shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -1.79%.
The Earnings Per Share has been growing by 12.01% on average over the past years. This is quite good.
HOLX shows a decrease in Revenue. In the last year, the revenue decreased by -2.37%.
HOLX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.61% yearly.
EPS 1Y (TTM)-1.79%
EPS 3Y-0.42%
EPS 5Y12.01%
EPS Q2Q%-2.83%
Revenue 1Y (TTM)-2.37%
Revenue growth 3Y2.19%
Revenue growth 5Y4.61%
Sales Q2Q%-0.85%

3.2 Future

Based on estimates for the next years, HOLX will show a small growth in Earnings Per Share. The EPS will grow by 7.33% on average per year.
The Revenue is expected to grow by 4.63% on average over the next years.
EPS Next Y5.05%
EPS Next 2Y7.12%
EPS Next 3Y8.02%
EPS Next 5Y7.33%
Revenue Next Year0.24%
Revenue Next 2Y2.82%
Revenue Next 3Y3.79%
Revenue Next 5Y4.63%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 19.26, which indicates a rather expensive current valuation of HOLX.
HOLX's Price/Earnings ratio is rather cheap when compared to the industry. HOLX is cheaper than 88.54% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 28.05. HOLX is valued slightly cheaper when compared to this.
With a Price/Forward Earnings ratio of 16.28, HOLX is valued correctly.
85.94% of the companies in the same industry are more expensive than HOLX, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.07, HOLX is valued at the same level.
Industry RankSector Rank
PE 19.26
Fwd PE 16.28

4.2 Price Multiples

87.50% of the companies in the same industry are more expensive than HOLX, based on the Enterprise Value to EBITDA ratio.
92.71% of the companies in the same industry are more expensive than HOLX, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 18.15
EV/EBITDA 14.38

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of HOLX may justify a higher PE ratio.
PEG (NY)3.82
PEG (5Y)1.6
EPS Next 2Y7.12%
EPS Next 3Y8.02%

0

5. Dividend

5.1 Amount

HOLX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

HOLOGIC INC

NASDAQ:HOLX (5/31/2024, 7:00:00 PM)

After market: 73.78 0 (0%)

73.78

+1.2 (+1.65%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap17.22B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 19.26
Fwd PE 16.28
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)3.82
PEG (5Y)1.6
Profitability
Industry RankSector Rank
ROA 5.35%
ROE 9.63%
ROCE
ROIC
ROICexc
ROICexgc
OM 22.37%
PM (TTM) 11.78%
GM 55.12%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 3.97
Quick Ratio 3.29
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-1.79%
EPS 3Y-0.42%
EPS 5Y
EPS Q2Q%
EPS Next Y5.05%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-2.37%
Revenue growth 3Y2.19%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y